Literature DB >> 19727624

[Radiotherapy : an option for refractory salivary fistulas].

H Christiansen1, H A Wolff, J Knauth, A Hille, H Vorwerk, C Engelke, R Rödel, R Laskawi.   

Abstract

A 45-year-old patient presented with refractory salivary fistula, attributed to multiple surgery and Botulinum toxin, following lateral parotidectomy. He underwent fractionated radiotherapy of the remaining parotid gland including the fistula opening (total dose of 30 Gy) at our clinic. In time, fistula secretion could be inhibited completely. Although the indication for radiotherapy for such fistulas is rare since Botulinum toxin has been in use, it should still be considered in refractory disease courses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19727624     DOI: 10.1007/s00106-009-1988-y

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  11 in total

Review 1.  Tolerance of normal tissue to therapeutic irradiation.

Authors:  B Emami; J Lyman; A Brown; L Coia; M Goitein; J E Munzenrider; B Shank; L J Solin; M Wesson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

Review 2.  Treatment of complications of parotid gland surgery.

Authors:  R Marchese-Ragona; C De Filippis; G Marioni; A Staffieri
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

3.  Heel spur radiotherapy and radiation carcinogenesis risk estimation.

Authors:  Serdar Surenkok; Bahar Dirican; Murat Beyzadeoglu; Kaan Oysul
Journal:  Radiat Med       Date:  2006-10

4.  Recurrent pleomorphic adenomas of the parotid gland: clinical evaluation and long-term follow-up.

Authors:  R Laskawi; T Schott; M Schröder
Journal:  Br J Oral Maxillofac Surg       Date:  1998-02       Impact factor: 1.651

5.  Low-dose radiation therapy for benign salivary disorders.

Authors:  D S Shimm; F K Berk; T J Tilsner; S W Coulthard
Journal:  Am J Clin Oncol       Date:  1992-02       Impact factor: 2.339

6.  The role of radiation therapy in the management of sialorrhea.

Authors:  M Borg; F Hirst
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-15       Impact factor: 7.038

7.  Surgical management of pleomorphic adenomas of the parotid gland: a follow-up study of three methods.

Authors:  R Laskawi; T Schott; M Mirzaie-Petri; M Schroeder
Journal:  J Oral Maxillofac Surg       Date:  1996-10       Impact factor: 1.895

8.  Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.

Authors:  Maik Ellies; Ulrike Gottstein; Saskia Rohrbach-Volland; Christian Arglebe; Rainer Laskawi
Journal:  Laryngoscope       Date:  2004-10       Impact factor: 3.325

9.  Treatment of an acute salivary fistula after parotid surgery: botulinum toxin type A injection as primary treatment.

Authors:  Young Chang Lim; Eun Chang Choi
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-08-18       Impact factor: 2.503

10.  Retrospective review of 242 consecutive patients treated surgically for parotid gland tumours.

Authors:  Farheen Mohammed; Jamil Asaria; Richard J Payne; Jeremy L Freeman
Journal:  J Otolaryngol Head Neck Surg       Date:  2008-06
View more
  8 in total

1.  [Drooling following radiation. Botulinum toxin as a successful treatment modality].

Authors:  A Steffen; B Wollenberg; R Schönweiler; N Brüggemann; T Meyners
Journal:  HNO       Date:  2011-01       Impact factor: 1.284

Review 2.  Hypersalivation: update of the German S2k guideline (AWMF) in short form.

Authors:  Armin Steffen; Wolfgang Jost; Tobias Bäumer; Dirk Beutner; Sabine Degenkolb-Weyers; Martin Groß; Maria Grosheva; Samer Hakim; Kai G Kahl; Rainer Laskawi; Rebekka Lencer; Jan Löhler; Thekla Meyners; Saskia Rohrbach-Volland; Rainer Schönweiler; Sara-Christina Schröder; Sebastian Schröder; Heidrun Schröter-Morasch; Maria Schuster; Susanne Steinlechner; Roland Urban; Orlando Guntinas-Lichius
Journal:  J Neural Transm (Vienna)       Date:  2019-04-10       Impact factor: 3.575

Review 3.  [Botulinum toxin in otorhinolaryngology - an update].

Authors:  R Laskawi; A Olthoff
Journal:  HNO       Date:  2017-10       Impact factor: 1.284

4.  Use of 2-Octyl-Cyanoacrylate in surgical closing of Postparotidectomy salivary fistulas.

Authors:  Zoran Pesic; Nikola Buric; Ivica Vuckovic; Dragan Petrovic; Dragan Krasic; Andrija Cosic; Ivana Djokic
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-08       Impact factor: 2.503

5.  Sialocele: A rare sequlae of transparotid approach in subcondylar fracture management.

Authors:  R Rajeev; S Sajesh; Mathew Jose; N Dhineksh Kumar
Journal:  Natl J Maxillofac Surg       Date:  2016 Jul-Dec

6.  Botulinum toxin treatment of salivary fistulas following parotidectomy: follow-up results.

Authors:  Rainer Laskawi; Jan Winterhoff; Sabrina Köhler; Laura Kottwitz; Christoph Matthias
Journal:  Oral Maxillofac Surg       Date:  2012-11-24

Review 7.  Therapy of Sialorrhea with Botulinum Neurotoxin.

Authors:  Wolfgang H Jost; Tobias Bäumer; Rainer Laskawi; Jaroslaw Slawek; Björn Spittau; Armin Steffen; Martin Winterholler; Ganesh Bavikatte
Journal:  Neurol Ther       Date:  2019-09-21

8.  The use of bipolar coagulation forceps prevented salivary fistula in patients with parotidectomy: a retrospective study.

Authors:  Kun Wu; Keke Zhu; Yingxi Ye; Sainan Li; Hanjiang Wu; Sheng Zhang
Journal:  BMC Oral Health       Date:  2021-08-06       Impact factor: 2.757

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.